- Although price ZSCore is at a high level but it has returned from prior high level and momentum has slowed down.
- RSI is at a high level of 79. A high level of RSI indicates the stock is overbought.
- MACD is crossing MACD signal line at 0.8. MACD crossing signal line is bullish signal.
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year 2020 before the Nasdaq market opens on Wednesday, February 10, 2021.
The Relative Strength (RS) Rating for Nevro climbed into a higher percentile Monday, as it got a lift from 65 to 71. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. See if Nevro can continue to rebound and hit that benchmark.
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced its participation in the 2021 ICR Conference, which is being held virtually January 11-14, 2021. Shakil Lakhani, President of North America, and Dr. Spero Theodorou, M.D., Chief Medical Officer, will participate in a fireside chat on Thursday, January 14, 2021 at 3:15 pm EST.
Zacks.com featured highlights include: Azure Power Global, Mueller Industries, H&E Equipment Services, Korea Electric Power and InMode
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced it will present a corporate social responsibility (CSR) strategy in its annual 20-F filing, to report the Company's sustainable practices as it continues to expand into new communities and markets. InMode's CSR strategy aims to positively impact the local economy, increase stakeholder engagement, and position the organization towards long-term sustainable success.
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Mr. Moshe Mizrahy, Chairman and Chief Executive Officer, and Mr. Yair Malca, Chief Financial Officer will present virtually at the 23rd Annual Needham Growth Conference on Thursday, January 14, 2021 at 8:30 am EST.
Exagen (XGN) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.